Literature DB >> 8081986

Effect of transforming growth factor-beta 1 on plasminogen activators and plasminogen activator inhibitor-1 in renal glomerular cells.

H M Wilson1, F J Reid, P A Brown, D A Power, N E Haites, N A Booth.   

Abstract

Recent evidence suggests that the balance between serine proteases and their inhibitors is central to the maintenance of the glomerular extracellular matrix. We have characterised the urokinase type and the tissue type plasminogen activators (PA) and their inhibitor, PAI-1, secreted from glomerular epithelial and mesangial cells as well as their co-cultures and have investigated the effect of transforming growth factor-beta 1 (TGF-beta 1) on the production of such species. Similar data were derived from whole glomeruli suspensions. TGF-beta 1 increased PAI-1 production significantly in epithelial and mesangial cells as well as in whole glomeruli, while PA production was decreased; platelet-derived growth factor had no effect. These effects are consistent with a possible decrease in matrix proteolysis, suggesting a mechanism by which TGF-beta 1 may enhance mesangial matrix accumulation, a characteristic of many forms of glomerular disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8081986

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  7 in total

Review 1.  TGF-β: the master regulator of fibrosis.

Authors:  Xiao-Ming Meng; David J Nikolic-Paterson; Hui Yao Lan
Journal:  Nat Rev Nephrol       Date:  2016-04-25       Impact factor: 28.314

2.  Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells.

Authors:  S M Wileman; N A Booth; N Moore; B Redmill; J V Forrester; R M Knott
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

Review 3.  Signaling pathways of chronic kidney diseases, implications for therapeutics.

Authors:  Qian Yuan; Ben Tang; Chun Zhang
Journal:  Signal Transduct Target Ther       Date:  2022-06-09

4.  Interaction of transforming growth factor beta 1 with human glomerular epithelial cells in culture: opposite effects on synthesis of matrix proteins and on urokinase plasminogen activator.

Authors:  C Wagner; C Viedt; A Bürger; S Filsinger; M Kramer; G M Hänsch
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

5.  Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis.

Authors:  A R Kitching; S R Holdsworth; V A Ploplis; E F Plow; D Collen; P Carmeliet; P G Tipping
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

Review 6.  RIPK3: A New Player in Renal Fibrosis.

Authors:  Ying Shi; Xinming Chen; Chunling Huang; Carol Pollock
Journal:  Front Cell Dev Biol       Date:  2020-06-16

7.  Treatment with lecinoxoids attenuates focal and segmental glomerulosclerosis development in nephrectomized rats.

Authors:  Niva Yacov; Boris Feldman; Alexander Volkov; Eti Ishai; Eyal Breitbart; Itzhak Mendel
Journal:  Basic Clin Pharmacol Toxicol       Date:  2018-09-19       Impact factor: 4.080

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.